Bio-Works Technologies AB (BIOWKS) — Cash Flow Quality Index
Latest as of June 2021:
1.05x
Bio-Works Technologies AB (BIOWKS) has a Cash Flow Quality Index of 1.05x as of June 2021. Operating cash flow of Skr9.35 Million exceeds net income of Skr8.88 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow to debt ratio of Bio-Works Technologies AB to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
1.05x
Operating CF / Net Income
Operating Cash Flow
Skr9.35 Million
SEK
Net Income
Skr8.88 Million
SEK
Data as of
Jun 2021
Most recent filing
Annual Cash Flow Quality Index for Bio-Works Technologies AB (None–None)
Year-by-year earnings quality comparison for Bio-Works Technologies AB.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.